首页 › 基金 › Euclidean Capital LLC › SRZN
Euclidean Capital LLC 对 SRZN 的持仓历史
SURROZEN INC · 医疗保健
Euclidean Capital LLC 在 Q3 2026 的 13F 申报中披露持有 SRZN(SURROZEN INC)87,696 股,市值约 US$2.8M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 7 位。 Euclidean Capital LLC 最近 13 个申报季度中有 13 个季度披露了 SRZN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Euclidean Capital LLC 对 SRZN 的持仓演变
Euclidean Capital LLC 于 Q3 2023 首次披露 SRZN 持仓:1,315,463 股(约 US$645K)。 该持仓在 Q3 2026 达到峰值 87,696 股,市值约 US$2.8M。 在 13 次申报中,Euclidean Capital LLC 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 87,696 股、市值约 US$2.8M。 持仓曾出现大幅变动:Q4 2023 减持约 93% (随后一个季度股价上涨 67%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.32M | $644.58K | 新进 |
| Q4 2023 | 87.70K | $824.34K | 减持 |
| Q1 2024 | 87.70K | $1.38M | 持有 |
| Q2 2024 | 87.70K | $960.27K | 持有 |
| Q3 2024 | 87.70K | $1.05M | 持有 |
| Q4 2024 | 87.70K | $1.26M | 持有 |
| Q1 2025 | 87.70K | $1.02M | 持有 |
| Q2 2025 | 87.70K | $784.00K | 持有 |
| Q3 2025 | 87.70K | $1.13M | 持有 |
| Q4 2025 | 87.70K | $1.98M | 持有 |
| Q1 2026 | 87.70K | $2.55M | 持有 |
| Q2 2026 | 87.70K | $2.28M | 持有 |
| Q3 2026 | 87.70K | $2.82M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SRZN 与 13F 数据
SRZN(SURROZEN INC)属于医疗保健行业。我们追踪的基金中还有 59 只申报持有 SRZN,申报仓位最大的包括:Column Group LLC (US$76.6M), Boxer Capital Management, LLC (US$43.8M), Commodore Capital LP (US$28.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SRZN 的基金
- Column Group LLC 2.95M 股 · $76.59M · Q3 2026
- Boxer Capital Management, LLC 1.36M 股 · $43.79M · Q3 2026
- Commodore Capital LP 885.00K 股 · $28.48M · Q3 2026
- Venrock Adviser, LLC 632.93K 股 · $20.37M · Q3 2026
- Kynam Capital Management, LP 486.25K 股 · $15.65M · Q3 2026
- Spruce Street Capital LP 432.04K 股 · $13.90M · Q3 2026
- STEMPOINT CAPITAL LP 418.53K 股 · $11.12M · Q3 2026
- Integral Health Asset Management, LLC 325.00K 股 · $10.46M · Q3 2026
- Kalehua Capital Management LLC 286.09K 股 · $9.21M · Q3 2026
- Vivo Capital, LLC 260.00K 股 · $8.37M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 152.54K 股 · $4.91M · Q3 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K 股 · $4.29M · Q3 2026
更多关于 Euclidean Capital LLC
常见问题
How long has Euclidean Capital LLC held SRZN?
Euclidean Capital LLC has disclosed SRZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Euclidean Capital LLC's current position in SRZN?
As of Q3 2026, Euclidean Capital LLC holds 87.70K shares of SRZN (SURROZEN INC), valued at $2.82M, representing 0.87% of its reported portfolio and ranking #7.
Has Euclidean Capital LLC been buying or selling SRZN?
In the latest 13F filing (Q3 2026), Euclidean Capital LLC held unchanged its position in SRZN. The position peaked in Q3 2026 at 87.70K shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include Column Group LLC, Boxer Capital Management, LLC, Commodore Capital LP, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.